S 4741 · 118th Congress · Health
PLASMA Act
Bill Progress
✓
Introduced2
Committee3
Senate Vote4
House5
EnactedLatest: Read twice and referred to the Committee on Finance.(2024-07-23)
Plain Language Summary
[AI summary unavailable — showing source text]
[Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [S. 4741 Introduced in Senate (IS)] <DOC> 118th CONGRESS 2d Session S. 4741 To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES July 23, 2024 Mr. Tillis (for himself and Mr. Kelly) introduced the following bill; which was read twice and referred to the Committee on Finance _______________________________________________________________________ A BILL To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Preserving Life-saving Access to Specialty Medicines in America Act'' or the ``PLASMA Act''. SEC. 2. PHASE-IN FOR PLASMA-DERIVED PRODUCTS UNDER MANUFACTURER DISCOUNT PROGRAM. Section 1860D-14C(g)(4) of the Social Security Act (42 U.S.C. 1395w-114c(g)(4)) is a…
Summarized by Claude AI · Non-partisan · For informational purposes only
Cosponsors (3)
2 Democrats1 Republican